期刊文献+

右美托咪定联合罗哌卡因对妊娠高血压分娩硬膜外镇痛的疗效 被引量:2

The effect of dexmedetomidine combined with ropivacaine on epidural analgesia in pregnant women with hypertension
下载PDF
导出
摘要 目的观察右美托咪定联合罗哌卡因对妊娠高血压硬膜外分娩镇痛的疗效。方法选择浙江省杭州市第九人民医院2018年1月-2020年3月收治的经阴道分娩的足月单胎妊娠高血压初产妇80例为研究对象,随机分为右美托咪定组和舒芬太尼组。右美托咪定组采用0.1%罗哌卡因+1μg/mL右美托咪定硬膜外分娩镇痛;舒芬太尼组采用0.1%罗哌卡因+0.5μg/mL舒芬太尼硬膜外分娩镇痛。观察两组生命体征、镇痛镇静效果、分娩情况,并记录镇痛期间恶心呕吐、皮肤瘙痒、呼吸抑制等不良反应的发生情况。结果与镇痛前(T0)比较,两组镇痛后30分钟(T1)、60分钟(T2)、第一产程结束时(T3)及第二产程结束时(T4)的Ramsay评分均显著增高,VAS评分均显著降低,差异有统计学意义(P<0.05)。T0与T1时Ramsay镇静评分、VAS镇痛评分两组间比较差异均无统计学意义(P>0.05);在T2-T4时Ramsay镇静评分右美托咪定组均高于舒芬太尼组,同时VAS镇痛评分均低于舒芬太尼组,差异有统计学意义(P<0.05)。与T0时比较,两组T1-T4时MAP、HR均显著降低(P<0.05)。在T0-T4各时间点MAP、SpO2组间比较,差异无统计学意义(P>0.05);右美托咪定组HR在T1-T4时低于舒芬太尼组,差异有统计学意义(P<0.05);两组产程时间、胎心率、新生儿Apgar评分、脐动脉血乳酸值,差异均无统计学意义(P>0.05)。右美托咪定组恶心呕吐、皮肤瘙痒发生率低于舒芬太尼组,差异有统计学意义(P<0.05)。结论右美托咪定联合罗哌卡因用于妊娠高血压产妇硬膜外分娩镇痛,具有良好的控制血压和镇痛、镇静效果,且恶心呕吐、皮肤瘙痒发生率低。
作者 王金忠 黎德旺 方萍 WANG Jinzhong;LI Dewang;FANG Ping
出处 《浙江实用医学》 2020年第5期331-334,共4页 Zhejiang Practical Medicine
基金 浙江省医学会临床科研基金项目(2017ZYC-A39)。
  • 相关文献

参考文献4

二级参考文献42

  • 1American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 2Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 3Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 4Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 5Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 6Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 7Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.
  • 8Churchill D, Beevers GD, Meher S, et al, Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007, 24 (1):CD004451.
  • 9McCoy S, Baldwin K. Pharmacotherapeutie options for the treatment of preeelampsia[J]. Am J Health Syst Pharm, 2009, 66(4):337-344.
  • 10Duley L, Gfilmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia[J]. Cochrane Database Syst Rev, 2010, 8(9):CD002960.

共引文献1494

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部